Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells

Journal of Nanoscience and Nanotechnology - United States
doi 10.1166/jnn.2015.10834
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Scientific Publishers

Related search

Ginsenoside Rg3Induces Apoptosis of Human Breast Cancer (MDA-MB-231) Cells

Journal of Cancer Prevention
2013English

The Treatment of MDA-MB-231 Breast Cancer Cells With Biocompatible Manganese Iron Oxide Nanoparticles as Drug Carriers

Biophysical Journal
Biophysics
2019English

MEKK2 Regulates Paxillin Ubiquitylation and Localization in MDA-MB 231 Breast Cancer Cells

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2014English

Magnetic Nanoparticles Sensitize McF-7 Breast Cancer Cells to Doxorubicin-Induced Apoptosis

World Journal of Surgical Oncology
SurgeryOncology
2012English

Anti-Cancer Effect of Apigenin on Human Breast Carcinoma MDA-MB-231 Through Cell Cycle Arrest and Apoptosis

Microbiology and Biotechnology Letters
Applied MicrobiologyBiotechnologyMicrobiology
2019English

Berberine Hydrochloride IL-8 Dependently Inhibits Invasion and IL-8-independently Promotes Cell Apoptosis in MDA-MB-231 Cells

Oncology Reports
MedicineCancer ResearchOncology
2014English

Suppression of Spry4 Enhances Cancer Stem Cell Properties of Human MDA-MB-231 Breast Carcinoma Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2016English

A Sesquiterpenoid From Farfarae Flos Induces Apoptosis of MDA-MB-231 Human Breast Cancer Cells Through Inhibition of JAK–STAT3 Signaling

Biomolecules
BiochemistryMolecular Biology
2019English

Correlation Between Slug Transcription Factor and miR-221 in MDA-MB-231 Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy